Both rapamycin and mTOR inhibitor PP242 were found to cause irreversible growth arrest on a range of head and neck cancer cells treated with radiotherapy including glioma cells [75], providing further evidence of the potential for pharmacological mTOR manipulation to be a viable treatment mechanism in addition to radiotherapy. This evidence concerns the gene MTOR and glioma.